Lab on a Chip

Lab on a Chip is a hybrid open-access journal launched by the Royal Society of Chemistry in 2001 and devoted to devices and applications at the micro- and nanoscale, publishing fundamental and applied work on miniaturised systems across chemistry, biology, medicine and engineering, with a 2025 Journal Impact Factor of 6.3.《芯片实验室》（Lab on a Chip）由英国皇家化学会于 2001 年创办，专注微纳尺度器件与应用，发表跨越化学、生物、医学与工程的微型化系统基础与应用研究，2025 年影响因子为 6.3。

Scope

• Fundamental understanding of micro and nano flows, soft matter principles and materials properties forms the physical foundation of the journal's coverage.微纳流动、软物质原理与材料性质的基础研究构成本刊覆盖范围的物理基础。
• Miniaturised devices and systems for high-throughput experiments are central, including biomarker discovery, drug screening, protein engineering, single-cell analysis, sequencing, synthetic biology and materials synthesis.用于高通量实验的微型化器件与系统是核心内容，包括生物标志物发现、药物筛选、蛋白质工程、单细胞分析、测序、合成生物学与材料合成。
• Micro-macro interfacing, spanning fluid handling at multiple scales, integration into experimental workflows and coupling to analytical instruments, is a standing topic.微观与宏观接口是常设主题，涵盖多尺度流体操控、与实验流程的集成以及与分析仪器的联用。
• Robotics and artificial intelligence interfacing, and automated or autonomous systems that collect and analyse large data sets, are increasingly prominent.机器人与人工智能接口，以及用于采集与分析大数据的自动化或自主系统，正日益受到重视。
• Integrated systems that combine multiple functions in a single device, and device development for sensing, actuation or light-matter interactions, are regularly published.把多种功能集成于单一器件的集成系统，以及面向传感、驱动或光物质相互作用的器件开发，均属常规发表内容。
• New miniaturised detection methodologies that improve sensitivity, throughput, usability, robustness or cost are a methodological priority.提升灵敏度、通量、易用性、稳健性或降低成本的新型微型化检测方法，是本刊的方法学重点。
• Organs-on-chip models beyond simple cell cultivation, chemical microreactors and synthesis in miniaturised devices beyond flow chemistry are explicitly sought.超越简单细胞培养的器官芯片模型，以及超越流动化学的微型化学反应器与微型化合成，均为本刊明确征稿方向。
• Diagnostic devices, point-of-care systems, healthcare medical devices, and integrated devices in textiles, materials and composites complete the scope.诊断器件、即时检验系统、医疗健康器械，以及集成于纺织品、材料与复合材料中的器件，共同构成本刊范围。

History

• The journal was founded in 2001 by the Royal Society of Chemistry as the field of microfluidics moved from analytical chemistry into biology and medicine.本刊由英国皇家化学会于 2001 年创办，当时微流控正从分析化学向生物学与医学拓展。
• It established itself as the flagship venue for miniaturisation research, a position reflected in its deliberately interdisciplinary readership across academia and industry.本刊确立了其在微型化研究领域的旗舰地位，其横跨学术界与产业界的多学科读者群正体现了这一点。
• The journal marked its twentieth anniversary in 2021, by which time organs-on-chip, single-cell analysis and diagnostic devices had become core subjects.本刊于 2021 年迎来创刊二十周年，此时器官芯片、单细胞分析与诊断器件已成为其核心主题。
• Publication follows a hybrid model, with subscription access alongside a gold open-access option for individual articles.本刊采用混合出版模式，在订阅获取之外允许单篇文章选择金色开放获取。
• The 2025 impact factor is 6.3, up from 5.4 in 2024, and the journal reports a first decision within 32 days for all submissions and 42 days for peer-reviewed papers.2025 年影响因子为 6.3，高于 2024 年的 5.4；全部投稿的首次决定中位时间为 32 天，经同行评审论文为 42 天。
• It is indexed in Web of Science SCIE, Scopus, PubMed, MEDLINE and CAS, and its eISSN is 1473-0189.本刊被 Web of Science 的 SCIE、Scopus、PubMed、MEDLINE 与 CAS 收录，电子 ISSN 为 1473-0189。

Editors

• The editor-in-chief is Aaron Wheeler of the University of Toronto, a pioneer of digital microfluidics whose laboratory develops droplet-based platforms for bioanalysis.主编为多伦多大学的 Aaron Wheeler，他是数字微流控的先驱，其实验室开发用于生物分析的液滴平台。
• Editorial board members are drawn from microfluidics, analytical chemistry, biomedical engineering, materials science and synthetic biology, matching the journal's interdisciplinary remit.编委来自微流控、分析化学、生物医学工程、材料科学与合成生物学等领域，与本刊的跨学科定位相匹配。
• The journal publishes full-length research papers and communications, and also carries comments, reviews and perspectives commissioned by the editors.本刊发表全文研究论文与通讯，并刊载由编辑组织的评论、综述与观点文章。
• Papers must demonstrate innovation arising either from technical advancement or from applications that address pressing needs in globally important areas.论文须体现创新性，创新可来自技术进步，也可来自应对全球重要领域迫切需求的应用。
• Submissions are handled through the Royal Society of Chemistry's ScholarOne system with external peer review, and authors may choose open access at acceptance.稿件通过英国皇家化学会的 ScholarOne 系统投稿并接受外部同行评审，作者可在录用时选择开放获取。
• Editorial policy favours work that advances miniaturisation itself, rather than routine applications of commercial microfluidic chips.编辑方针偏好推动微型化本身进步的工作，而非对商用微流控芯片的常规应用。